These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response. Marcel V; Fernandes K; Terrier O; Lane DP; Bourdon JC Cell Death Differ; 2014 Sep; 21(9):1377-87. PubMed ID: 24926616 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers. Gudikote JP; Cascone T; Poteete A; Sitthideatphaiboon P; Wu Q; Morikawa N; Zhang F; Peng S; Tong P; Li L; Shen L; Nilsson M; Jones P; Sulman EP; Wang J; Bourdon JC; Johnson FM; Heymach JV J Biol Chem; 2021 Nov; 297(5):101163. PubMed ID: 34481841 [TBL] [Abstract][Full Text] [Related]
4. p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients. Bourdon JC; Khoury MP; Diot A; Baker L; Fernandes K; Aoubala M; Quinlan P; Purdie CA; Jordan LB; Prats AC; Lane DP; Thompson AM Breast Cancer Res; 2011 Jan; 13(1):R7. PubMed ID: 21251329 [TBL] [Abstract][Full Text] [Related]
5. Functional characterization of p53beta and p53gamma, two isoforms of the tumor suppressor p53. Graupner V; Schulze-Osthoff K; Essmann F; Jänicke RU Cell Cycle; 2009 Apr; 8(8):1238-48. PubMed ID: 19305147 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence. Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358 [TBL] [Abstract][Full Text] [Related]
7. Role of p53β in the inhibition of proliferation of gastric cancer cells expressing wild-type or mutated p53. Ji W; Ma J; Zhang H; Zhong H; Li L; Ding N; Jiao J; Gao Z Mol Med Rep; 2015 Jul; 12(1):691-5. PubMed ID: 25695150 [TBL] [Abstract][Full Text] [Related]
8. Identification of nonsense-mediated mRNA decay pathway as a critical regulator of p53 isoform β. Cowen LE; Tang Y Sci Rep; 2017 Dec; 7(1):17535. PubMed ID: 29235495 [TBL] [Abstract][Full Text] [Related]
9. p53β: a new prognostic marker for patients with clear-cell renal cell carcinoma from 5.3 years of median follow-up. Zhang H; Zhao Y; Sun P; Zhao M; Su Z; Jin X; Song W Carcinogenesis; 2018 Mar; 39(3):368-374. PubMed ID: 29346503 [TBL] [Abstract][Full Text] [Related]
10. High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma. Bischof K; Knappskog S; Stefansson I; McCormack EM; Trovik J; Werner HMJ; Woie K; Gjertsen BT; Bjorge L BMC Cancer; 2018 Jun; 18(1):684. PubMed ID: 29940909 [TBL] [Abstract][Full Text] [Related]
11. p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy. Haaland I; Hjelle SM; Reikvam H; Sulen A; Ryningen A; McCormack E; Bruserud Ø; Gjertsen BT Cells; 2021 Apr; 10(4):. PubMed ID: 33917201 [TBL] [Abstract][Full Text] [Related]
12. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression. Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133 [TBL] [Abstract][Full Text] [Related]
13. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles. Oh L; Hainaut P; Blanchet S; Ariffin H BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553 [TBL] [Abstract][Full Text] [Related]
14. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Fujita K; Mondal AM; Horikawa I; Nguyen GH; Kumamoto K; Sohn JJ; Bowman ED; Mathe EA; Schetter AJ; Pine SR; Ji H; Vojtesek B; Bourdon JC; Lane DP; Harris CC Nat Cell Biol; 2009 Sep; 11(9):1135-42. PubMed ID: 19701195 [TBL] [Abstract][Full Text] [Related]
15. The Balance between p53 Isoforms Modulates the Efficiency of HIV-1 Infection in Macrophages. Breton Y; Barat C; Tremblay MJ J Virol; 2021 Sep; 95(20):e0118821. PubMed ID: 34379507 [TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells. Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676 [TBL] [Abstract][Full Text] [Related]
17. Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ. Solomon H; Sharon M; Rotter V Cell Death Differ; 2014 Sep; 21(9):1347-9. PubMed ID: 25109594 [No Abstract] [Full Text] [Related]
18. Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels. Yan D; Zheng X; Tu L; Jia J; Li Q; Cheng L; Wang X Mol Med Rep; 2015 Jan; 11(1):295-302. PubMed ID: 25352209 [TBL] [Abstract][Full Text] [Related]
20. Effect of p53β on human gastric cancer cells treated with recombinant mutated human TNF and cisplatin. Ji W; Yuan M; Zhang L; Zhang H; Jiao J; Gao Z Mol Med Rep; 2017 Jun; 15(6):3865-3870. PubMed ID: 28393225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]